About LAXAI
LAXAI is a Healthcare company based in Hyderabad (India) founded in 2007 by Vamsi Maddipatla. Drug discovery and development services are provided by LAXAI. The company has 345 employees. LAXAI has completed 1 acquisition, including OSR Solutions. Its chief executive, as recorded, is Vamsi Maddipatla. Its Indian entity Laxai Life Sciences Private Limited reported revenue of ₹178 Cr. LAXAI offers products and services including Integrated Drug Discovery, Chemical Process Development, Manufacturing Services, and Specialty Chemicals. Its focus areas include Biopharma Outsourcing, Diversified and Small Molecules & Peptides.
Company details
LAXAI was founded in 2007 and is headquartered in Hyderabad, India. Drug discovery and development services are offered within the pharmaceutical sector. Operations are centered on supporting research and innovation for clients in biotechnology. The company is led by Co-Founder and CEO Vamsi Maddipatla, with activities focused on advancing therapeutic solutions through structured development processes.
- Headquarters Hyderabad, India
- Employees 345
- Founders Vamsi Maddipatla
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website laxai.com
- Social LinkedIn Facebook Instagram YouTube
- Legal Name Laxai Life Sciences Private Limited
- Date of Incorporation 10 Jul, 2006
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹178 Cr
FY 2024 · +37% YoY
- Net Profit₹6.75 Cr
FY 2024 · 4% margin
- EBITDA₹20.02 Cr
FY 2024 · 11% margin
- Investors
- Employee Count345
- Investments & Acquisitions
Associated legal entities of LAXAI
LAXAI operates through Laxai Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Laxai Life Sciences Private Limited CIN U24119TG2006PTC050583 | Active | 10 Jul 2006 | Hyderabad, Telangana | ₹178 Cr | 345 | 6 | View details |
Products & Services of LAXAI
LAXAI offers a comprehensive portfolio of products and services, including Integrated Drug Discovery, Chemical Process Development, Manufacturing Services, and Specialty Chemicals.
Services for drug programs from target identification to IND filing.
Optimizes routes for efficient chemical manufacturing processes.
Provides supplies for pre-clinical to commercial phases.
Offers custom synthesis of fine chemicals and intermediates.
Apps and channels of LAXAI
its YouTube channel Laxai Life Sciences has 68 subscribers and 5 videos.
Videos from LAXAI
The most watched videos on LAXAI's YouTube channel, Laxai Life Sciences (68 subscribers). Click a video to play it here.
More on Laxai Life Sciences.
Funding Insights of LAXAI
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of LAXAI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2022 | Private Equity Round | – | – |
1 investors in total: 1 institutional.
Investors in LAXAI
LAXAI has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Signet Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
PE firm investing in North America and Europe | signethealthcarepartners.com | New York, United States |
Investor details for LAXAI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Laxai Life Sciences Private Limited (LAXAI)
Laxai Life Sciences Private Limited is the primary company behind LAXAI. The board of Laxai Life Sciences Private Limited currently have 3 directors; the longest-serving is Nikhil Puri, appointed in 2023. 18 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nikhil Puri DIN 10064045 | Director | 23 Mar 2023 | 3 yrs 7 mo | Laxai Life Sciences Private Limited |
| Lavanya Gali DIN 03078041 | Director | 28 Mar 2023 | 3 yrs 7 mo | Laxai Life Sciences Private Limited |
| Venkatraman Ganesh DIN 10929899 | Director | 21 Mar 2025 | 1 yr 7 mo | Laxai Life Sciences Private Limited |
People of LAXAI
8 people are tracked at LAXAI (6 in leadership, 2 in team); the tracked headcount is 345.
| Name | Role | Group |
|---|---|---|
Vamsi Maddipatla | Co-Founder & CEO | Leadership |
Dr. Ashwinkumar V Meru | Vice President, Global Business Development | Leadership |
| President | Leadership | |
Ramesh Mullangi | Executive Vice President | Leadership |
Madan Reddy | Chief Financial Officer | Leadership |
James Schwindeman | Director Of Business Development | Leadership |
Ranjith Reddy | Senior Executive Business Development | Team |
Deepak Kumar M | Information Technology Manager | Team |
Complete people profiles for LAXAI
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of LAXAI
Figures of Laxai Life Sciences Private Limited, the primary company behind LAXAI, for FY 2024. Revenue was ₹178 Cr (+37% year on year). Net profit was ₹6.75 Cr (4% margin). EBITDA was ₹20.02 Cr (11% margin). Revenue has grown at a compounded annual rate of +57% over three years and +49% over five years.
- ₹178 CrRevenue · FY 2024 · +37% YoY
- ₹6.75 CrNet profit · 4% margin
- ₹20.02 CrEBITDA · 11% margin
- ₹27.79 CrPaid-up capital
- 345Employees (provident fund records)
- +57%Revenue CAGR, 3 years
- +49%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Laxai Life Sciences Private Limited are on its company page.
Detailed financial statements for LAXAI
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LAXAI
LAXAI has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include OSR Solutions.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Strategic consulting services are provided to business clients. | osrsolutions.com | Edison, United States | 2001 | Mar 2010 | $3.6M |
Complete acquisition details for LAXAI
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of LAXAI
3 dated milestones of LAXAI across 15 years, from founding to its latest funding, stage changes and deals.
- Founded LAXAI is founded.
- Acquisition Acquires OSR Solutions.
- Funding First funding round.
Web traffic of LAXAI
The website of LAXAI (laxai.com) receives about 2.1K visits a month.
- Monthly visits2.1K
▲ 17.9% vs previous month
Websites whose visitors overlap most with LAXAI. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| centrahubhcm.com | 100% | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as LAXAI (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Laxai
Complete news archive for LAXAI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LAXAI
LAXAI was founded in 2007 and raised its 1st funding round 15 years after it was founded.
LAXAI is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Vamsi Maddipatla is the CEO of LAXAI, as recorded in our data. They have also founded this company.
LAXAI has 345 employees.
The primary company behind LAXAI, Laxai Life Sciences Private Limited, reported revenue of ₹178 Cr for FY 2024, up 37% year on year.
LAXAI was founded in 2007 and is headquartered in Hyderabad, India. Drug discovery and development services are offered within the pharmaceutical sector. Operations are centered on supporting research and innovation for clients in biotechnology. The company is led by Co-Founder and CEO Vamsi Maddipatla, with activities focused on advancing therapeutic solutions through structured development processes.
LAXAI offers Integrated Drug Discovery, Chemical Process Development, Manufacturing Services, and Specialty Chemicals.
LAXAI has made 1 acquisition, including OSR Solutions.
LAXAI has 1 investor. Key investors include Signet Healthcare Partners.
LAXAI operates through Laxai Life Sciences Private Limited.
The legal entities of LAXAI currently have 6 directors, including Lavanya Gali, Madan Mohan Reddy Sambatur, Preeti . Agarwal and others.